title: Initiatives promoting seamless care in medication management: an international review of the grey literature.
abstract: BACKGROUND
  Patients' transition between hospital and community is a high-risk period for the occurrence of medication-related problems.
  
  
  OBJECTIVE
  The objective was to review initiatives, implemented at national and regional levels in seven selected countries, aiming at improving continuity in medication management upon admission and hospital discharge.
  
  
  METHODS
  We performed a structured search of grey literature, mainly through relevant websites (scientific, professional and governmental organizations). Regional or national initiatives were selected. For each initiative data on the characteristics, impact, success factors and barriers were extracted. National experts were asked to validate the initiatives identified and the data extracted.
  
  
  RESULTS
  Most initiatives have been implemented since the early 2000 and are still ongoing. The principal actions include: development and implementation of guidelines for healthcare professionals, national information campaigns, education of healthcare professionals and development of information technologies to share data across settings of care. Positive results have been partially reported in terms of intake into practice or process measures. Critical success factors identified included: leadership and commitment to convey national and local forces, tailoring to local settings, development of a regulatory framework and information technology support. Barriers identified included: lack of human and financial resources, questions relative to responsibility and accountability, lack of training and lack of agreement on privacy issues.
  
  
  CONCLUSIONS
  Although not all initiatives are applicable as such to a particular healthcare setting, most of them convey very interesting data that should be used when drawing recommendations and implementing approaches to optimize continuity of care.
authors.forename: Coraline
authors.initials: C
authors.lastname: Claeys
authors.forename: Veerle
authors.initials: V
authors.lastname: Foulon
authors.forename: Sabrina
authors.initials: S
authors.lastname: de Winter
authors.forename: Anne
authors.initials: A
authors.lastname: Spinewine
mesh_terms: D003266:Continuity of Patient Care / Q000458:organization & administration*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D006282:Health Personnel / Q000458:organization & administration; D006801:Humans; D007857:Leadership; D054539:Medication Therapy Management / Q000458:organization & administration*; D010343:Patient Admission / Q000592:standards; D010351:Patient Discharge; D017410:Practice Guidelines as Topic
references.citation: Int J Qual Health Care. 2013 Sep;25(4):403-17
references.pmid: 23639854
references.citation: Public Health. 2012 Jan;126(1):12-7
references.pmid: 22130477
references.citation: Br J Clin Pharmacol. 2008 Feb;65(2):265-9
references.pmid: 17764470
references.citation: Aust New Zealand Health Policy. 2009 Sep 22;6:24
references.pmid: 19772663
references.citation: Pharm World Sci. 2010 Aug;32(4):449-54
references.pmid: 20446111
references.citation: Ugeskr Laeger. 2011 Oct 31;173(44):2793-7
references.pmid: 22040661
references.citation: Ann Pharmacother. 2012 Apr;46(4):484-94
references.pmid: 22414793
references.citation: Ann Pharmacother. 2006 Mar;40(3):408-13
references.pmid: 16492794
references.citation: Arch Intern Med. 2007 May 28;167(10):1034-40
references.pmid: 17533206
references.citation: J Am Med Inform Assoc. 2010 Mar-Apr;17(2):203-11
references.pmid: 20190065
references.citation: J Epidemiol Community Health. 2005 Sep;59(9):804-8
references.pmid: 16100321
references.citation: J Gen Intern Med. 2005 Apr;20(4):317-23
references.pmid: 15857487
references.citation: Arch Intern Med. 2012 Jul 23;172(14):1057-69
references.pmid: 22733210
references.citation: J Gen Intern Med. 2010 Jan;25 Suppl 1:62-7
references.pmid: 20077154
references.citation: Ugeskr Laeger. 2006 Aug 28;168(35):2887-90
references.pmid: 16982016
references.citation: Qual Saf Health Care. 2009 Dec;18(6):478-85
references.pmid: 19955461
references.citation: Ann Pharmacother. 2008 Oct;42(10):1373-9
references.pmid: 18780806
references.citation: Eur J Intern Med. 2012 Dec;23(8):696-700
references.pmid: 23021790
references.citation: CMAJ. 2011 Mar 22;183(5):E281-8
references.pmid: 21343262
references.citation: Ann Pharmacother. 2009 Jun;43(6):1001-10
references.pmid: 19491320
references.citation: Br J Clin Pharmacol. 2011 Aug;72(2):338-49
references.pmid: 21426371
references.citation: CMAJ. 2005 Aug 30;173(5):510-5
references.pmid: 16129874
references.citation: Med J Aust. 2008 Jun 16;188(12):732-3; author reply 733
references.pmid: 18558901
references.citation: Qual Saf Health Care. 2010 Jun;19(3):164-8
references.pmid: 20194218
references.citation: Arch Intern Med. 2005 Sep 12;165(16):1842-7
references.pmid: 16157827
references.citation: Ned Tijdschr Geneeskd. 2010;154:A904
references.pmid: 20356426
references.citation: Soc Sci Med. 2009 Dec;69(12):1767-76
references.pmid: 19854551
references.citation: Qual Saf Health Care. 2006 Apr;15(2):122-6
references.pmid: 16585113
references.citation: Ann Pharmacother. 2009 Oct;43(10):1667-75
references.pmid: 19737997
references.citation: Int J Clin Pharm. 2013 Feb;35(1):14-21
references.pmid: 22972383